Login
$STRW
$12.53 -$0.14 (1.1%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Assets
Real estate investments, net
Cash and cash equivalents
Restricted cash and equivalents
Straight-line rent receivable, net
Right of use lease asset
Goodwill, other intangible assets and lease rights
Deferred financing expenses
Notes receivable, net
Notes receivable, carrying amount
Other assets
Total Assets
Liabilities
Accounts payable and accrued liabilities
Bonds, net
Note payable
Senior debt
Operating lease liability
Other liabilities
Total Liabilities
Equity
Common stock, $.0001 par value, 500,000,000 shares authorized, 14,069,238 shares and 13,257,425 issued and outstanding
Additional paid in capital
Accumulated other comprehensive loss
Retained earnings
Total Stockholders’ Equity
Non-controlling interest
Total Equity
Total Liabilities and Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support